Valhalla Ventures
Los Angeles, United States15
6M
13
3.75
0.13
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 66000000
- Fund raised date
- 2023-07-25
Analytics
- Total investments
- 15
- Lead investments
- 0
- Rounds per year
- 3.75
- Follow on index
- 0.13
- Investments by industry
- Software (4)
- Gaming (4)
- eSports (2)
- Mobile Apps (2)
- Developer Platform (2) Show 33 more
- Investments by region
- United States (12)
- Canada (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 3
- Group Appearance index
- 0.93
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 1v1Me | 27 Jun 2022 | Mobile, Gaming, eSports, Mobile Apps | Seed | 2M | United States, New York, New York |
| Lockchain.ai | 01 Apr 2024 | Seed | 4M | United States, New York, New York |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Smart Bricks , a San Francisco, CA-based AI startup building agentic AI infrastructure for real-estate investing | Nov 2, 2026 | AI, Real-Estate Investing | Early stage | 5000000 USD | CA-based AI startup, a San Francisco |
| Merge Labs, co-founded by Sam Altman and building devices that connect human brains to computers | Jan 16, 2026 | Brain-Computer Interfaces, Brain-Tech, Healthcare | - | 252000000 USD | co-founded by Sam Altman |
| Converge Bio , a Boston, MA-based provider of an AI platform for accelerated drug discovery and development | Jan 13, 2026 | AI, Autoimmune Diseases, Drug Discovery, Neurodegenerative Diseases, Oncology | - | 25000000 USD | MA-based provider of an AI platform for accelerated drug discovery and development, a Boston |
| Arya Health | Oct 29, 2025 | AI, Healthcare, Home Health, Post-Acute Care, Workforce Automation | - | 18200000 USD | New York |
| Clarity | Sep 16, 2025 | AI agents, AI-powered customer-experience platform, highly regulated industries, support automation, voice-of-customer (VoC) platform | - | 12000000 USD |  London, |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.